Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018

ClinicalTrials.gov ID: NCT00945490

Public ClinicalTrials.gov record NCT00945490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 9:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the safety and efficacy of a 2.5 mg dose of NX-1207 for the treatment of BPH (benign prostatic hyperplasia) as compared to placebo.

Study identification

NCT ID
NCT00945490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nymox Corporation
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
45 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2009
Primary completion
Apr 30, 2014
Completion
Apr 30, 2014
Last update posted
Mar 9, 2017

2009 – 2014

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
For information concerning this clinical site, please contact Nymox at 800-936-9669. Laguna Hills California 92653
For information concerning this clinical site, please contact Nymox at 800-936-9669. San Diego California 92103
For information concerning this clinical site, please contact Nymox at 800-936-9669. San Diego California 92120
For information concerning this clinical site, please contact Nymox at 800-936-9669. Tarzana California 91356
For information concerning this clinical site, please contact Nymox at 800-936-9669. Torrance California 90505
For information concerning this clinical site, please contact Nymox at 800-936-9669. Denver Colorado 80220
For information concerning this clinical site, please contact Nymox at 800-936-9669. Englewood Colorado 80113
For information concerning this clinical site, please contact Nymox at 800-936-9669. Aventura Florida 33180
For information concerning this clinical site, please contact Nymox at 800-936-9669. Ocala Florida 34474
For information concerning this clinical site, please contact Nymox at 800-936-9669. Orlando Florida 32803
For information concerning this clinical site, please contact Nymox at 800-936-9669. Sarasota Florida 34237
For information concerning this clinical site, please contact Nymox at 800-936-9669. Meridian Idaho 83642
For information concerning this clinical site, please contact Nymox at 800-936-9669. Annapolis Maryland 21401
For information concerning this clinical site, please contact Nymox at 800-936-9669. Baltimore Maryland 21237
For information concerning this clinical site, please contact Nymox at 800-936-9669. Glen Burnie Maryland 21061
For information concerning this clinical site, please contact Nymox at 800-936-9669. Towson Maryland 21204
For information concerning this clinical site, please contact Nymox at 800-936-9669 Grand Rapids Michigan 49546
For information concerning this clinical site, please contact Nymox at 800-936-9669. Sartell Minnesota 56377
For information concerning this clinical site, please contact Nymox at 800-936-9669. Southaven Mississippi 38671
For information concerning this clinical site, please contact Nymox at 800-936-9669. Las Vegas Nevada 89146
For information concerning this clinical site, please contact Nymox at 800-936-9669. Las Vegas Nevada 89148
For information concerning this clinical site, please contact Nymox at 800-936-9669. Brick New Jersey 08724
For information concerning this clinical site, please contact Nymox at 800-936-9669. Albuquerque New Mexico 87109
For information concerning this clinical site, please contact Nymox at 800-936-9669. Albany New York 12208
For information concerning this clinical site, please contact Nymox at 800-936-9669. Garden City New York 11530
For information concerning this clinical site, please contact Nymox at 800-936-9669. New York New York 10016
For information concerning this clinical site, please contact Nymox at 800-936-9669. Bismarck North Dakota 58501
For information concerning this clinical site, please contact Nymox at 800-936-9669. Oklahoma City Oklahoma 73104
For information concerning this clinical site, please contact Nymox at 800-936-9669. Bryn Mawr Pennsylvania 19010
For information concerning this clinical site, please contact Nymox at 800-936-9669. Sewickley Pennsylvania 15143
For information concerning this clinical site, please contact Nymox at 800-936-9669. Memphis Tennessee 38119
For information concerning this clinical site, please contact Nymox at 800-936-9669. Houston Texas 77024
For information concerning this clinical site, please contact Nymox at 800-936-9669. McAllen Texas 78503
For information concerning this clinical site, please contact Nymox at 800-936-9669. San Antonio Texas 78229
For information concerning this clinical site, please contact Nymox at 800-936-9669. Richmond Virginia 23235

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00945490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 9, 2017 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00945490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →